Skip to main content

Advertisement

Log in

Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations

  • Published:
AAPS PharmSci Aims and scope Submit manuscript

Abstract

Our objective was to evaluate the application of polyoxyethylene homopolymers in buccal bioadhesive drug (BBD) delivery device formulations. The bioadhesive strength of four different molecular weight (MW) polyoxyethylene polymers was measured by Instronâ tensile tester using glass plate and bovine sublingual tissue as substrate surfaces. Several BBD device formulations containing polyoxyethylene polymer (MW 7,000,000) were prepared by direct compression and compression molding processes. The prepared BBD devices were evaluated for their elasticity, in vitro adhesion and drug release characteristics. The in vivo bioadhesion characteristics of a placebo compression molded device were examined in 3 adult healthy male beagle dogs. The bioadhesive strength of polyoxyethylene polymers appeared to be directly related to their molecular weights. When bovine sublingual mucosa or a glass plate was used as model mucosal substrate surface, the rank order of bioadhesive strength of different molecular weight polyoxyethylene polymers was similar. The bioadhesive strength of devices prepared by the compression molding process was greater than those prepared by direct compression, but the kinetics of drug release were independent of the process used for the preparation of the devices. The drug release and the bioadhesive strength of the similarly prepared device formulations appeared to be dependent on the drug:polymer ratios. The elasticity of the BBD devices prepared by compression molding was improved by the inclusion of polyisobutylene polymer in the formulations. When adhered to the oral cavity of the dogs, the compression molded placebo BBD device exhibited adhesion for at least 4 hours and appeared to show no signs of local irritation. In conclusion, BBD devices containing polyoxyethylene polymer (MW 7,000,000) can be prepared by direct compression or compression molding process in order to provide controlled drug release to the oral cavity while maintaining appropriate bioadhesive characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Veillard MM, Longer MA, Martens TW, Robinson JR. Preliminary studies of oral mucosal delivery of peptide drugs. J Controlled Release. 1987;6:123–131.

    Article  CAS  Google Scholar 

  2. Ponchel G. Formulation of oral mucosal drug delivery systems for the systemic delivery of bioactive materials. Adv Drug Delivery Rev. 1994;13:75–87.

    Article  CAS  Google Scholar 

  3. Jimenez-Castellanos MR, Zia H, Rhodes CT. Mucoadhesive drug delivery systems. Drug Dev Ind Pharm. 1993;19:143–194.

    Article  CAS  Google Scholar 

  4. Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm. 1988;14:283–318.

    Article  CAS  Google Scholar 

  5. Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. Int J Pharmacol. 1984;19:107–127.

    Article  CAS  Google Scholar 

  6. Helliwell M. The use of bioadhesives in targeted delivery within the gastrointestinal tract. Adv Drug Delivery Rev. 1993;11:221–251.

    Article  CAS  Google Scholar 

  7. Gupta A, Garg S, Khar RK. Interpolymer complexation and its effect on bioadhesive strength and dissolution characteristics of buccal delivery systems. Drug Dev Ind Pharm. 1994;20:315–325.

    Article  CAS  Google Scholar 

  8. Satoh K, Takayama K, Machida Y, Suzuki Y, Nakagaki M, Nagai T. Factors affecting the bioadhesive property of tablet consisting of hydroxy propyl cellulose and carboxyvinyl polymer. Chem Pharm Bull. 1989;37:1366–1368.

    Article  CAS  PubMed  Google Scholar 

  9. Chen JL, Cyr GN. Compositions producing adhesion through hydration (Chapter 10). In: Manly RS, ed. Adhesive Biological Systems. New York, NY: Academic Press; 1970:163–181.

    Chapter  Google Scholar 

  10. Merkle HP, Wolany G. Buccal delivery of peptide drugs. J Controlled Release. 1992;21:155–164.

    Article  CAS  Google Scholar 

  11. Mortazavi SA, Smart JD. An in vitro method for assessing the duration of mucoadhesion. J Controlled Release. 1994;31:201–212.

    Article  Google Scholar 

  12. Smart JD. An in vitro assessment of some mucosa-adhesive dosage forms. Int J Pharmacol. 1991;73:69–74.

    Article  CAS  Google Scholar 

  13. Smart JD. Drug delivery using buccal-adhesive systems. Adv Drug Delivery Rev. 1993;11:253–270.

    Article  CAS  Google Scholar 

  14. Bottenberg P, Cleymae R, Muynck C, Remon JP, Coomans D, Michotte Y, Slop D. Development and testing of bioadhesive fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol. 1991;43:457–464.

    Article  CAS  PubMed  Google Scholar 

  15. Bottenberg P, Cleymae R, Muynck C, Remon JP, Coomans D, Slop D. Comparison of salivary fluoride concentrations after administration of a bioadhesive slow-release tablet and a conventional fluoride tablet. J Pharm Pharmacol. 1992;44:684–686.

    Article  CAS  PubMed  Google Scholar 

  16. SentryÒ PolyoxÒ WSR, NF- Polyethylene oxide [product literature]. Danbury, Conn: Union Carbide; 1995.

    Google Scholar 

  17. Eckhart CG, McCorkle T. Chlorpheniramine maleate. In: Florey K, ed. Analytical Profiles of Drug Substances-Volume 7. New York, NY: Academic Press; 1978:45–80.

    Google Scholar 

  18. Schott H. Polymer Science. In: Martin A, Bustamante P, Chun AHC, eds. Physical Pharmacy. Malvern, PA: Lea & Febiger, 1993:578–579.

    Google Scholar 

  19. Cherukuri SR, Friello DR, Ferroti M, Jewell W, D'Amelia RP, inventors; Nabisco Brands Inc. New York, NY Gum base, chewing gum containing same and method. US patent 4,352,822. Oct. 5, 1982.

  20. Mackay DAM, Warren K, Witzel F, Schoenholz D, inventors; Life Savers Inc. New York, NY. Long-lasting flavored chewing gum including chalk-free gum base. US patent 4,062,274. Dec. 20, 1977.

  21. Song JH, Greenberg MJ, Record DW, Zibell SE, Broderick K, Schnell PG, inventors; Wrigley, Jr. Co. Chicago, IL. Gum composition containing dispersed porous beads containing active chewing gum ingredients and methods. US patent 5,154,927. Oct. 13, 1992.

  22. Broderick KB, Record DW, inventors; Wrigley, Jr. Co. Chicago, IL. Gum composition containing dispersed porous beads containing active chewing gum ingredients and method. US patent 5,139,787. Aug. 18, 1992.

  23. K. Satoh, K. Takayama, Y. Machida, Y. Suzuki, M. Nakagaki and T. Nagai. Factors affecting the bioadhesive property of tablet consisting of hydroxy propyl cellulose and carboxyvinyl polymer. Chem. Pharm. Bull. 1989;37:1366–1368.

    Article  CAS  PubMed  Google Scholar 

  24. M. Pederson and M.R. Rassing. Miconazole chewing gum as a drug delivery system test of release promoting additives. Drug Dev. Ind. Pharm. 1991;17:411–420.

    Article  Google Scholar 

  25. T. Anderson, M. Gram-Hansen, M. Pedersen and M.R. Rassing. Chewing gum as a delivery system for nystatin influence of solubilizing agents upon the release of water insoluble drugs. Drug Dev. Ind. Pharm. 1990;16:1985–1994.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Deepak Tiwari.

Additional information

Published: September 15, 1999.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tiwari, D., Sause, R., Madan, P.L. et al. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci 1, 13 (1999). https://doi.org/10.1208/ps010313

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/ps010313

Key words

Navigation